APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Type 2 Diabetes Industry Growth and Trends Forecast to 2032

Report ID 174043950122 December 202592 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Type 2 Diabetes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 2 Diabetes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 2 Diabetes include Sanofi, Novo Nordisk, Merck, Eli Lily, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, Biocon and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Type 2 Diabetes market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Type 2 Diabetes market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Type 2 Diabetes market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Type 2 Diabetes.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Type 2 Diabetes market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Type 2 Diabetes Market by Company

Sanofi

Novo Nordisk

Merck

Eli Lily

AstraZeneca

Daiichi Sankyo

Boehringer Ingelheim

Biocon

Astellas Pharma

Type 2 Diabetes Segment by Type

DPP-4 Inhibitors

GLP-1 Receptor Agonists

SGLT-2 Inhibitors

Insulins

Type 2 Diabetes Segment by Application

Drugstore

Hospital

Others

Type 2 Diabetes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Type 2 Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DPP-4 Inhibitors Table 2. Major Company of GLP-1 Receptor Agonists Table 3. Major Company of SGLT-2 Inhibitors Table 4. Major Company of Insulins Table 5. Global Type 2 Diabetes Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 7. Global Type 2 Diabetes Sales Market Share in Volume by Type (2021-2026) Table 8. Global Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 9. Global Type 2 Diabetes Sales Market Share in Value by Type (2021-2026) Table 10. Global Type 2 Diabetes Price by Type (2021-2026) & (US$/unit) Table 11. Global Type 2 Diabetes Sales by Type (2027-2032) & (k units) Table 12. Global Type 2 Diabetes Sales Market Share in Volume by Type (2027-2032) Table 13. Global Type 2 Diabetes Sales by Type (2027-2032) & (US$ Million) Table 14. Global Type 2 Diabetes Sales Market Share in Value by Type (2027-2032) Table 15. Global Type 2 Diabetes Price by Type (2027-2032) & (US$/unit) Table 16. North America Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 17. North America Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 19. Europe Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 23. Latin America Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Type 2 Diabetes Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Type 2 Diabetes Sales by Type (2021-2026) & (US$ Million) Table 26. Type 2 Diabetes Industry Trends Table 27. Type 2 Diabetes Industry Drivers Table 28. Type 2 Diabetes Industry Opportunities and Challenges Table 29. Type 2 Diabetes Industry Restraints Table 30. Global Type 2 Diabetes Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Type 2 Diabetes Revenue Market Share by Company (2021-2026) Table 32. Global Type 2 Diabetes Sales by Company (2021-2026) & (k units) Table 33. Global Type 2 Diabetes Sales Share by Company (2021-2026) Table 34. Global Type 2 Diabetes Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Type 2 Diabetes Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Type 2 Diabetes Major Company Production Sites and Headquarters Table 37. Global Type 2 Diabetes Company, Product Type & Application Table 38. Global Type 2 Diabetes Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Type 2 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Type 2 Diabetes Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Type 2 Diabetes Sales by Region (2021-2026) & (k units) Table 43. Global Type 2 Diabetes Sales Market Share in Volume by Region (2021-2026) Table 44. Global Type 2 Diabetes Sales by Region (2021-2026) & (US$ Million) Table 45. Global Type 2 Diabetes Sales Market Share in Value by Region (2021-2026) Table 46. Global Type 2 Diabetes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Type 2 Diabetes Sales by Region (2027-2032) & (k units) Table 48. Global Type 2 Diabetes Sales Market Share in Volume by Region (2027-2032) Table 49. Global Type 2 Diabetes Sales by Region (2027-2032) & (US$ Million) Table 50. Global Type 2 Diabetes Sales Market Share in Value by Region (2027-2032) Table 51. Global Type 2 Diabetes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Type 2 Diabetes Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 54. Global Type 2 Diabetes Sales Market Share in Volume by Application (2021-2026) Table 55. Global Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 56. Global Type 2 Diabetes Sales Market Share in Value by Application (2021-2026) Table 57. Global Type 2 Diabetes Price by Application (2021-2026) & (US$/unit) Table 58. Global Type 2 Diabetes Sales by Application (2027-2032) & (k units) Table 59. Global Type 2 Diabetes Sales Market Share in Volume by Application (2027-2032) Table 60. Global Type 2 Diabetes Sales by Application (2027-2032) & (US$ Million) Table 61. Global Type 2 Diabetes Sales Market Share in Value by Application (2027-2032) Table 62. Global Type 2 Diabetes Price by Application (2027-2032) & (US$/unit) Table 63. North America Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 64. North America Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 66. Europe Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 70. Latin America Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Type 2 Diabetes Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Type 2 Diabetes Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Type 2 Diabetes Product Portfolio Table 77. Sanofi Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Novo Nordisk Type 2 Diabetes Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Merck Type 2 Diabetes Product Portfolio Table 87. Merck Recent Development Table 88. Eli Lily Company Information Table 89. Eli Lily Business Overview Table 90. Eli Lily Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Eli Lily Type 2 Diabetes Product Portfolio Table 92. Eli Lily Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Type 2 Diabetes Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Type 2 Diabetes Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Type 2 Diabetes Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Biocon Company Information Table 109. Biocon Business Overview Table 110. Biocon Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Biocon Type 2 Diabetes Product Portfolio Table 112. Biocon Recent Development Table 113. Astellas Pharma Company Information Table 114. Astellas Pharma Business Overview Table 115. Astellas Pharma Type 2 Diabetes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Astellas Pharma Type 2 Diabetes Product Portfolio Table 117. Astellas Pharma Recent Development Table 118. North America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. North America Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 120. North America Type 2 Diabetes Sales Market Share by Country (2021-2026) Table 121. North America Type 2 Diabetes Sales Forecast by Country (2027-2032) & (k units) Table 122. North America Type 2 Diabetes Sales Market Share Forecast by Country (2027-2032) Table 123. North America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Type 2 Diabetes Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Type 2 Diabetes Market Share by Country (2021-2026) Table 126. North America Type 2 Diabetes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Type 2 Diabetes Market Share Forecast by Country (2027-2032) Table 128. Europe Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Europe Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 130. Europe Type 2 Diabetes Sales Market Share by Country (2021-2026) Table 131. Europe Type 2 Diabetes Sales Forecast by Country (2027-2032) & (k units) Table 132. Europe Type 2 Diabetes Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Type 2 Diabetes Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Type 2 Diabetes Market Share by Country (2021-2026) Table 136. Europe Type 2 Diabetes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Type 2 Diabetes Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 140. Asia-Pacific Type 2 Diabetes Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Type 2 Diabetes Sales Forecast by Country (2027-2032) & (k units) Table 142. Asia-Pacific Type 2 Diabetes Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Type 2 Diabetes Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Type 2 Diabetes Market Share by Country (2021-2026) Table 146. Asia-Pacific Type 2 Diabetes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Type 2 Diabetes Market Share Forecast by Country (2027-2032) Table 148. Latin America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Latin America Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 150. Latin America Type 2 Diabetes Sales Market Share by Country (2021-2026) Table 151. Latin America Type 2 Diabetes Sales Forecast by Country (2027-2032) & (k units) Table 152. Latin America Type 2 Diabetes Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Type 2 Diabetes Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Type 2 Diabetes Market Share by Country (2021-2026) Table 156. Latin America Type 2 Diabetes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Type 2 Diabetes Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Type 2 Diabetes Sales by Country (2021-2026) & (k units) Table 160. Middle East and Africa Type 2 Diabetes Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Type 2 Diabetes Sales Forecast by Country (2027-2032) & (k units) Table 162. Middle East and Africa Type 2 Diabetes Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Type 2 Diabetes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Type 2 Diabetes Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Type 2 Diabetes Market Share by Country (2021-2026) Table 166. Middle East and Africa Type 2 Diabetes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Type 2 Diabetes Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Type 2 Diabetes Distributors List Table 171. Type 2 Diabetes Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Type 2 Diabetes Image Figure 2. Global Type 2 Diabetes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 2 Diabetes Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 2 Diabetes Sales (2021-2032) & (k units) Figure 5. DPP-4 Inhibitors Image Figure 6. Global DPP-4 Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. GLP-1 Receptor Agonists Image Figure 8. Global GLP-1 Receptor Agonists Sales YoY Growth (2021-2032) & (k units) Figure 9. SGLT-2 Inhibitors Image Figure 10. Global SGLT-2 Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 11. Insulins Image Figure 12. Global Insulins Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Type 2 Diabetes Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Type 2 Diabetes Market Share by Type 2025 VS 2032 Figure 15. North America Type 2 Diabetes Sales Market Share in Volume by Type in 2025 Figure 16. North America Type 2 Diabetes Sales Market Share in Value by Type in 2025 Figure 17. Europe Type 2 Diabetes Sales Market Share in Volume by Type in 2025 Figure 18. Europe Type 2 Diabetes Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Type 2 Diabetes Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Type 2 Diabetes Sales Market Share in Value by Type in 2025 Figure 21. Latin America Type 2 Diabetes Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Type 2 Diabetes Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Type 2 Diabetes Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Type 2 Diabetes Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Type 2 Diabetes Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Drugstore Image Figure 28. Global Drugstore Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Type 2 Diabetes Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Type 2 Diabetes Market Share by Application 2025 VS 2032 Figure 35. North America Type 2 Diabetes Sales Market Share in Volume by Application in 2025 Figure 36. North America Type 2 Diabetes Sales Market Share in Value by Application in 2025 Figure 37. Europe Type 2 Diabetes Sales Market Share in Volume by Application in 2025 Figure 38. Europe Type 2 Diabetes Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Type 2 Diabetes Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Type 2 Diabetes Sales Market Share in Value by Application in 2025 Figure 41. Latin America Type 2 Diabetes Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Type 2 Diabetes Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Type 2 Diabetes Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Type 2 Diabetes Sales Market Share in Value by Application in 2025 Figure 45. North America Type 2 Diabetes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Type 2 Diabetes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Type 2 Diabetes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Type 2 Diabetes Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Type 2 Diabetes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Type 2 Diabetes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Type 2 Diabetes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Type 2 Diabetes Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Type 2 Diabetes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Type 2 Diabetes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Type 2 Diabetes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Type 2 Diabetes Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Type 2 Diabetes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Type 2 Diabetes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Type 2 Diabetes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Type 2 Diabetes Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Type 2 Diabetes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Type 2 Diabetes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Type 2 Diabetes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Type 2 Diabetes Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Type 2 Diabetes Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Type 2 Diabetes Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • DPP-4 Inhibitors
  • GLP-1 Receptor Agonists
  • SGLT-2 Inhibitors
  • Insulins
Applications
  • Drugstore
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lily
  • AstraZeneca
  • Daiichi Sankyo
  • Boehringer Ingelheim
  • Biocon
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Type 2 Diabetes Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Type 2 Diabetes Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Type 2 Diabetes Market by Type
  6. 1.3.1 DPP-4 Inhibitors
  7. 1.3.2 GLP-1 Receptor Agonists
  8. 1.3.3 SGLT-2 Inhibitors
  9. 1.3.4 Insulins
  10. 1.4 Global Type 2 Diabetes Market Size by Type
  11. 1.4.1 Global Type 2 Diabetes Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Type 2 Diabetes Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Type 2 Diabetes Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Type 2 Diabetes Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Type 2 Diabetes Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Type 2 Diabetes Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Type 2 Diabetes Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Type 2 Diabetes Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Type 2 Diabetes Industry Trends
  2. 2.2 Type 2 Diabetes Industry Drivers
  3. 2.3 Type 2 Diabetes Industry Opportunities and Challenges
  4. 2.4 Type 2 Diabetes Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Type 2 Diabetes Revenue (2021-2026)
  2. 3.2 Global Top Players by Type 2 Diabetes Sales (2021-2026)
  3. 3.3 Global Top Players by Type 2 Diabetes Price (2021-2026)
  4. 3.4 Global Type 2 Diabetes Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Type 2 Diabetes Major Company Production Sites & Headquarters
  6. 3.6 Global Type 2 Diabetes Company, Product Type & Application
  7. 3.7 Global Type 2 Diabetes Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Type 2 Diabetes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Type 2 Diabetes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Type 2 Diabetes Tier 1, Tier 2, and Tier 3
4 Type 2 Diabetes Regional Status and Outlook
  1. 4.1 Global Type 2 Diabetes Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Type 2 Diabetes Historic Market Size by Region
  3. 4.2.1 Global Type 2 Diabetes Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Type 2 Diabetes Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Type 2 Diabetes Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Type 2 Diabetes Forecasted Market Size by Region
  7. 4.3.1 Global Type 2 Diabetes Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Type 2 Diabetes Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Type 2 Diabetes Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Type 2 Diabetes by Application
  1. 5.1 Type 2 Diabetes Market by Application
  2. 5.1.1 Drugstore
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Type 2 Diabetes Market Size by Application
  6. 5.2.1 Global Type 2 Diabetes Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Type 2 Diabetes Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Type 2 Diabetes Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Type 2 Diabetes Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Type 2 Diabetes Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Type 2 Diabetes Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Type 2 Diabetes Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Type 2 Diabetes Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Type 2 Diabetes Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Type 2 Diabetes Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Type 2 Diabetes Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Eli Lily
  20. 6.4.1 Eli Lily Company Information
  21. 6.4.2 Eli Lily Business Overview
  22. 6.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lily Type 2 Diabetes Product Portfolio
  24. 6.4.5 Eli Lily Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Type 2 Diabetes Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Daiichi Sankyo
  32. 6.6.1 Daiichi Sankyo Company Information
  33. 6.6.2 Daiichi Sankyo Business Overview
  34. 6.6.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Daiichi Sankyo Type 2 Diabetes Product Portfolio
  36. 6.6.5 Daiichi Sankyo Recent Developments
  37. 6.7 Boehringer Ingelheim
  38. 6.7.1 Boehringer Ingelheim Company Information
  39. 6.7.2 Boehringer Ingelheim Business Overview
  40. 6.7.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Boehringer Ingelheim Type 2 Diabetes Product Portfolio
  42. 6.7.5 Boehringer Ingelheim Recent Developments
  43. 6.8 Biocon
  44. 6.8.1 Biocon Company Information
  45. 6.8.2 Biocon Business Overview
  46. 6.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biocon Type 2 Diabetes Product Portfolio
  48. 6.8.5 Biocon Recent Developments
  49. 6.9 Astellas Pharma
  50. 6.9.1 Astellas Pharma Company Information
  51. 6.9.2 Astellas Pharma Business Overview
  52. 6.9.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Astellas Pharma Type 2 Diabetes Product Portfolio
  54. 6.9.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Type 2 Diabetes Sales by Country
  2. 7.1.1 North America Type 2 Diabetes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Type 2 Diabetes Sales by Country (2021-2026)
  4. 7.1.3 North America Type 2 Diabetes Sales Forecast by Country (2027-2032)
  5. 7.2 North America Type 2 Diabetes Market Size by Country
  6. 7.2.1 North America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Type 2 Diabetes Market Size by Country (2021-2026)
  8. 7.2.3 North America Type 2 Diabetes Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Type 2 Diabetes Sales by Country
  2. 8.1.1 Europe Type 2 Diabetes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Type 2 Diabetes Sales by Country (2021-2026)
  4. 8.1.3 Europe Type 2 Diabetes Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Type 2 Diabetes Market Size by Country
  6. 8.2.1 Europe Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Type 2 Diabetes Market Size by Country (2021-2026)
  8. 8.2.3 Europe Type 2 Diabetes Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Type 2 Diabetes Sales by Country
  2. 9.1.1 Asia-Pacific Type 2 Diabetes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Type 2 Diabetes Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Type 2 Diabetes Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Type 2 Diabetes Market Size by Country
  6. 9.2.1 Asia-Pacific Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Type 2 Diabetes Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Type 2 Diabetes Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Type 2 Diabetes Sales by Country
  2. 10.1.1 South America Type 2 Diabetes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Type 2 Diabetes Sales by Country (2021-2026)
  4. 10.1.3 South America Type 2 Diabetes Sales Forecast by Country (2027-2032)
  5. 10.2 South America Type 2 Diabetes Market Size by Country
  6. 10.2.1 South America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Type 2 Diabetes Market Size by Country (2021-2026)
  8. 10.2.3 South America Type 2 Diabetes Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Type 2 Diabetes Sales by Country
  2. 11.1.1 Middle East and Africa Type 2 Diabetes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Type 2 Diabetes Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Type 2 Diabetes Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Type 2 Diabetes Market Size by Country
  6. 11.2.1 Middle East and Africa Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Type 2 Diabetes Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Type 2 Diabetes Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Type 2 Diabetes Value Chain Analysis
  2. 12.1.1 Type 2 Diabetes Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Type 2 Diabetes Production Mode & Process
  7. 12.2 Type 2 Diabetes Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Type 2 Diabetes Distributors
  10. 12.2.3 Type 2 Diabetes Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst